![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Open AccessEvolution of anti-modified protein antibody responses can be driven by consecutive exposure to different post-translational modifications
Besides anti-citrullinated protein antibodies (ACPA), rheumatoid arthritis patients (RA) often display autoantibody reactivities against other post-translationally modified (PTM) proteins, more specifically ca...
-
Article
Open AccessImmunoprofiling of early, untreated rheumatoid arthritis using mass cytometry reveals an activated basophil subset inversely linked to ACPA status
Autoantibody production is a hallmark of rheumatoid arthritis (RA). Anti-citrullinated protein antibodies (ACPA) are highly disease-specific, and their presence is associated with more severe disease and poor ...
-
Article
Open AccessInflammation functions as a key mediator in the link between ACPA and erosion development: an association study in Clinically Suspect Arthralgia
Anti-citrullinated protein antibodies (ACPA) are associated with more severe joint erosions in rheumatoid arthritis (RA), but the underlying mechanism is unclear. Recent in vitro and murine studies indicate th...
-
Article
Inflammatory genes TNFα and IL6 display no signs of increased H3K4me3 in circulating monocytes from untreated rheumatoid arthritis patients
Innate immune cells, such as monocytes, can adopt a long-lasting pro-inflammatory phenotype, a phenomenon called ‘trained immunity’. In trained immunity, increased cytokine levels of genes, like interleukin (I...
-
Article
A novel long non-coding RNA in the rheumatoid arthritis risk locus TRAF1-C5 influences C5 mRNA levels
Long non-coding RNAs (lncRNAs) can regulate the transcript levels of genes in the same genomic region. These locally acting lncRNAs have been found deregulated in human disease and some have been shown to harb...
-
Chapter
Dendritic Cells and their Potential Implication in Pathology and Treatment of Rheumatoid Arthritis
Dendritic cells (DC) are the professional antigen presenting cells that protect us against invading organisms. On the other hand, they uphold tolerance thereby avoiding the initiation of autoimmunity. In perfo...
-
Article
Characterization of an immuno ‘stealth’ derivative of the herpes simplex virus thymidine-kinase gene
The cellular immune response against transgene-encoded neoantigens is a potential hurdle in gene therapy applications where long-term expression of transgenes is desired. Here a new optimized derivative of the he...
-
Article
Creation of immune ‘stealth’ genes for gene therapy through fusion with the Gly-Ala repeat of EBNA-1
A major obstacle in gene-therapy protocols is T-cell-mediated destruction of transgene-expressing cells. Therefore new approaches are needed to prevent rapid clearance of transduced cells. We exploited the Gly...
-
Chapter
Interplay Between Human Papillomaviruses and Dendritic Cells
The design of the human papillomavirus (HPV) infection cycle is tightly fitted to the differentiation program of its natural host, the keratinocyte. This has important consequences for the role of antigen-pres...
-
Article
The role of CD40 in peripheral T cell tolerance and immunity
CD40 and CD40 ligand (CD40L) have been implicated as important molecules for the transformation of nonactivated antigen-presenting cells (APC) into cells that are potent inducers of cytotoxic T lymphocyte (CTL...
-
Article
A dual function for CD40 agonists
CD40 ligation serves as a powerful mediator of protective and therapeutic immunity against foreign invaders and cancer cells in vivo. A study now shows that agonistic antibodies against CD40 may also be useful in...
-
Chapter
Peptide Vaccination
T Lymphocytes are capable of eradication of both virus- and non-virus induced tumor cells [1, 2]. The highly diverse repertoire of T cells and the increased knowledge of the recognized ligands make it possible...
-
Chapter
Vaccination Strategies to Induce T-Cell Immunity Against Tumours
Effector T cells recognize immunogenic peptides that are presented on the cell membrane in the context of major histocompatibility complex (MHC) molecules. The vast majority of T cells consists of either CD8+ ...